TickerFacts.

Aligos Therapeutics, Inc. (ALGS): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2024-11-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2020-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

6.18M
As of 2025-12-31
6.24M
As of 2026-06-30
42.92M2019-12-31: 3.93M2020-12-31: 38.12M2021-12-31: 42.69M2022-12-31: 42.92M2023-12-31: 3.00M2024-12-31: 3.86M2025-12-31: 6.18M6.18M
2019-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-316.18M+59.9%2026-03-05, Balance as of period end
2024-12-313.86M+28.6%2026-03-05, Balance as of period end
2023-12-313.00Mn/c2025-03-10, Balance as of period end
2022-12-3142.92M+0.5%2024-03-12, Balance as of period end
2021-12-3142.69M+12.0%2023-03-09, Balance as of period end
2020-12-3138.12Mn/c2022-03-10, Balance as of period end
2019-12-313.93Mn/a2021-03-23, Balance as of period end